WEBSITE BSE:542920 NSE : SUMICHEM 06 Sep, 16:03
Market Cap ₹26867 Cr.
Stock P/E 61.8
P/B 10.5
Current Price ₹538.3
Book Value ₹ 51.5
Face Value 10
52W High ₹567
Dividend Yield 1.1%
52W Low ₹ 336.4
Sumitomo Chemical India Ltd engages within the manufacture and sale of household and public health insecticides, agricultural pesticides, and animal nutrition merchandise in India and internationally. The agency operates through two segments, Agro Chemicals and Others. It gives crop protection merchandise, including insecticides, herbicides, fungicides, and miticides; plant nutrition and plant growth regulators; fumigants and rodenticides; methionine; and organic products. Sumitomo Chemical India Ltd also exports its merchandise. The company incorporated in 2000 and is based in Mumbai, India. Sumitomo Chemical India Ltd is a subsidiary of Sumitomo Chemical Company Ltd.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) |
---|
Net Sales |
Other Income |
Total Income |
Total Expenditure |
Operating Profit |
Interest |
Depreciation |
Exceptional Income / Expenses |
Profit Before Tax |
Provision for Tax |
Profit After Tax |
Adjustments |
Profit After Adjustments |
Adjusted Earnings Per Share |
#(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 651 | 706 | 765 | 799 | 1911 | 2223 | 2423 | 2643 | 3060 | 3511 | 2833 | |
Other Income | 3 | 8 | 26 | 11 | 31 | 8 | 11 | 19 | 36 | 52 | 96 | |
Total Income | 655 | 714 | 791 | 809 | 1941 | 2231 | 2434 | 2662 | 3096 | 3563 | 2929 | |
Total Expenditure | 604 | 649 | 676 | 695 | 1691 | 1933 | 2088 | 2155 | 2458 | 2849 | 2358 | |
Operating Profit | 51 | 65 | 115 | 114 | 250 | 297 | 346 | 507 | 638 | 713 | 570 | |
Interest | 2 | 1 | 1 | 1 | 5 | 5 | 7 | 7 | 8 | 6 | 5 | |
Depreciation | 6 | 6 | 7 | 7 | 24 | 28 | 41 | 47 | 45 | 52 | 61 | |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | -7 | -31 | 0 | 0 | 0 | 0 | |
Profit Before Tax | 43 | 58 | 107 | 106 | 221 | 258 | 267 | 453 | 586 | 655 | 503 | |
Provision for Tax | 10 | 23 | 42 | 43 | 76 | 91 | 62 | 108 | 152 | 152 | 134 | |
Profit After Tax | 33 | 35 | 65 | 64 | 145 | 167 | 206 | 345 | 434 | 503 | 370 | |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Profit After Adjustments | 33 | 35 | 65 | 64 | 145 | 167 | 206 | 345 | 434 | 503 | 370 | |
Adjusted Earnings Per Share | 1.4 | 1.5 | 2.8 | 2.3 | 5.3 | 6.1 | 4.1 | 6.9 | 8.7 | 10.1 | 7.4 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | -19% | 2% | 5% | 16% |
Operating Profit CAGR | -20% | 4% | 14% | 27% |
PAT CAGR | -26% | 2% | 17% | 27% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 19% | 9% | NA% | NA% |
ROE Average | 15% | 21% | 22% | 20% |
ROCE Average | 21% | 29% | 29% | 28% |
#(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
Shareholder's Funds | 197 | 231 | 296 | 733 | 939 | 1035 | 1209 | 1528 | 1924 | 2380 | 2440 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | -3 | -0 | 3 | 3 | 33 | 30 | 43 | 50 | 61 | 54 | 63 |
Total Current Liabilities | 243 | 223 | 278 | 284 | 672 | 781 | 839 | 1080 | 1024 | 935 | 784 |
Total Liabilities | 436 | 454 | 576 | 1020 | 1644 | 1846 | 2091 | 2658 | 3009 | 3368 | 3287 |
Fixed Assets | 47 | 51 | 52 | 53 | 267 | 279 | 319 | 309 | 390 | 430 | 489 |
Other Non-Current Assets | 16 | 18 | 18 | 398 | 45 | 39 | 40 | 59 | 97 | 151 | 155 |
Total Current Assets | 374 | 385 | 506 | 570 | 1332 | 1528 | 1732 | 2290 | 2522 | 2787 | 2644 |
Total Assets | 436 | 454 | 576 | 1020 | 1644 | 1846 | 2091 | 2658 | 3009 | 3368 | 3287 |
#(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 18 | 29 | 25 | 72 | 49 | 65 | 39 | 82 | 177 | 57 | 47 |
Cash Flow from Operating Activities | 20 | 4 | 52 | -21 | 49 | 75 | 222 | 424 | 223 | 389 | 756 |
Cash Flow from Investing Activities | 8 | -8 | -5 | -289 | -40 | -35 | -118 | -282 | -281 | -327 | -426 |
Cash Flow from Financing Activities | -1 | 0 | -0 | 276 | 7 | -65 | -61 | -47 | -63 | -73 | -331 |
Net Cash Inflow / Outflow | 27 | -4 | 47 | -34 | 16 | -26 | 43 | 95 | -120 | -10 | -1 |
Closing Cash & Cash Equivalent | 29 | 25 | 72 | 38 | 65 | 39 | 82 | 177 | 57 | 47 | 46 |
# | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 1.42 | 1.49 | 2.77 | 2.32 | 5.28 | 6.08 | 4.12 | 6.92 | 8.69 | 10.09 | 7.41 |
CEPS(Rs) | 1.69 | 1.76 | 3.09 | 2.57 | 6.15 | 7.09 | 4.94 | 7.85 | 9.59 | 11.13 | 8.64 |
DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 2.29 | 0.55 | 0.8 | 1 | 1.2 | 5.9 |
Book NAV/Share(Rs) | 8.44 | 9.93 | 12.71 | 26.69 | 26.03 | 29.53 | 24.22 | 30.61 | 38.55 | 47.68 | 48.89 |
Core EBITDA Margin(%) | 6.88 | 7.46 | 10.8 | 12.02 | 11.19 | 11.59 | 12.28 | 16.08 | 17.1 | 16.7 | 14.76 |
EBIT Margin(%) | 6.43 | 7.72 | 13.01 | 12.45 | 11.54 | 10.5 | 10.05 | 15.17 | 16.85 | 16.7 | 15.84 |
Pre Tax Margin(%) | 6.2 | 7.64 | 12.94 | 12.31 | 11.26 | 10.31 | 9.79 | 14.95 | 16.63 | 16.54 | 15.67 |
PAT Margin (%) | 4.78 | 4.58 | 7.81 | 7.38 | 7.4 | 6.67 | 7.53 | 11.39 | 12.31 | 12.7 | 11.51 |
Cash Profit Margin (%) | 5.69 | 5.41 | 8.71 | 8.18 | 8.62 | 7.79 | 9.03 | 12.93 | 13.58 | 14.01 | 13.43 |
ROA(%) | 8.26 | 7.82 | 12.54 | 7.99 | 10.89 | 9.57 | 10.44 | 14.54 | 15.31 | 15.79 | 11.11 |
ROE(%) | 18.42 | 16.27 | 24.5 | 12.39 | 20.04 | 21.89 | 20.36 | 25.24 | 25.13 | 23.39 | 15.34 |
ROCE(%) | 24.67 | 27.42 | 40.83 | 20.9 | 26.88 | 26.21 | 24.24 | 33.62 | 34.4 | 30.74 | 21.11 |
Receivable days | 75.32 | 74.1 | 74.09 | 85.18 | 71.79 | 88.98 | 101.37 | 101.94 | 87.48 | 82.4 | 93.94 |
Inventory Days | 78.62 | 84.84 | 93.42 | 108.33 | 82.21 | 93.75 | 84.68 | 80.72 | 87.63 | 84.12 | 84.91 |
Payable days | 127.88 | 123.94 | 128.79 | 120.27 | 115.74 | 143.16 | 120.71 | 132.86 | 117.43 | 89.23 | 102.78 |
PER(x) | 0 | 0 | 0 | 0 | 0 | 0 | 44.53 | 42.04 | 51.73 | 42.16 | 46.91 |
Price/Book(x) | 0 | 0 | 0 | 0 | 0 | 0 | 7.58 | 9.5 | 11.66 | 8.92 | 7.11 |
Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0.3 | 0.28 | 0.22 | 0.28 | 1.7 |
EV/Net Sales(x) | 0.31 | 0.29 | 0.21 | 0.3 | 0.11 | 0.11 | 3.74 | 5.41 | 7.31 | 5.96 | 6.06 |
EV/Core EBITDA(x) | 4.01 | 3.2 | 1.4 | 2.07 | 0.88 | 0.85 | 26.21 | 28.2 | 35.02 | 29.33 | 30.12 |
Net Sales Growth(%) | 31.71 | 8.35 | 8.43 | 4.34 | 139.29 | 16.34 | 9.01 | 9.05 | 15.8 | 14.73 | -19.32 |
EBIT Growth(%) | 220.08 | 31.73 | 83.5 | -0.15 | 110.24 | 16.22 | 4.41 | 67.66 | 29.08 | 11.44 | -23.11 |
PAT Growth(%) | 159.41 | 5.03 | 85.6 | -1.37 | 127.63 | 15.11 | 23.13 | 67.92 | 25.61 | 16.07 | -26.57 |
EPS Growth(%) | 159.42 | 5.02 | 85.6 | -16.32 | 127.63 | 15.1 | -32.26 | 67.92 | 25.61 | 16.07 | -26.57 |
Debt/Equity(x) | 0 | 0 | 0 | 0 | 0.01 | 0.02 | 0 | 0 | 0 | 0 | 0 |
Current Ratio(x) | 1.54 | 1.73 | 1.82 | 2 | 1.98 | 1.96 | 2.06 | 2.12 | 2.46 | 2.98 | 3.37 |
Quick Ratio(x) | 0.86 | 0.88 | 0.97 | 1.03 | 1.08 | 1.09 | 1.36 | 1.42 | 1.55 | 2.03 | 2.6 |
Interest Cover(x) | 28 | 88.52 | 166.97 | 91.83 | 42.06 | 55.37 | 38.9 | 67.35 | 75.29 | 106.76 | 95.1 |
Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
# | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 |
FII | 1.69 | 1.9 | 2.05 | 2.44 | 2.4 | 2.51 | 2.58 | 2.61 | 2.75 | 3.07 |
DII | 6.35 | 6.7 | 6.4 | 5.52 | 5.51 | 5.5 | 6.07 | 6.02 | 6.64 | 7.14 |
Public | 16.95 | 16.4 | 16.55 | 17.03 | 17.09 | 16.98 | 16.35 | 16.36 | 15.62 | 14.8 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 37.44 | 37.44 | 37.44 | 37.44 | 37.44 | 37.44 | 37.44 | 37.44 | 37.44 | 37.44 |
FII | 0.85 | 0.95 | 1.02 | 1.22 | 1.2 | 1.25 | 1.29 | 1.31 | 1.37 | 1.53 |
DII | 3.17 | 3.34 | 3.2 | 2.76 | 2.75 | 2.75 | 3.03 | 3.01 | 3.31 | 3.56 |
Public | 8.46 | 8.19 | 8.26 | 8.5 | 8.53 | 8.48 | 8.16 | 8.17 | 7.79 | 7.39 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 49.91 | 49.91 | 49.91 | 49.91 | 49.91 | 49.91 | 49.91 | 49.91 | 49.91 | 49.91 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About